EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Sub-ulcer foam sclerotherapy in patients with venous ulceration: A randomized controlled trial

Toni Pihlaja iD, Pasi Ohtonen, Pekka Romsi, Matti Pokela

Phlebology: The Journal of Venous Disease · 2025

DOI: 10.1177/02683555241304030 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Phlebology: The Journal of Venous Disease, 2025. Verfasst von Toni Pihlaja und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Vascular Surgery, Oulu University Hospital, Oulu, Finland. Hauptthemen laut MEDLINE: Sclerotherapy, Varicose Ulcer, Sclerosing Solutions. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 14 Literaturangaben. Gefördert von: Finland’s state funding for the university level.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

This trial analyzed the effect of sub-ulcer foam sclerotherapy in patients with venous leg ulcer (VLU).

Design

Randomized controlled trial.

Methods

This trial recruited patients with VLUs to receive either sub-ulcer foam sclerotherapy and compression therapy (study group) or compression therapy only (control group). The primary outcome of this study was the change in the venous ulcer area at 4 weeks. The feasibility, safety, and complications of the sub-ulcer foam sclerotherapy were recorded.

Results

Of 23 patients included, 12 were randomized to study group and 11 to control group. Preoperatively, the average ulcer areas were 5.8 cm 2 in both groups. At 4 weeks, the average reductions in ulcer areas were 4.0 cm 2 (SD 3.1) in the study group (95% CI 2.0 to 5.9, p = .001) and 2.0 cm 2 (SD 3.1) in the control group (95% CI: −0.1 to 4.1, p = .051). No differences in complications were recorded.

Conclusions

At 1-month sub-ulcer foam sclerotherapy and compression therapy reduced the ulcer area statistically significantly, whereas compression therapy alone did not. Sub-ulcer foam sclerotherapy could be a good addition to superficial venous insufficiency treatment in patients with VLU. ClinicalTrials.gov identifier NCT03795064.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SclerotherapyVaricose UlcerSclerosing SolutionsHumansMaleFemaleMiddle AgedAgedAdult

Stichwörter der Autor:innen

cerendothermal ablationfoam sclerotherapyvenous ul

Substanzen

Sclerosing Solutions

Autor:innen und Institutionen

  • Department of Vascular Surgery, Oulu University Hospital, Oulu, Finland.
  • Research Service Unit, Oulu University Hospital, Oulu, Finland.

ORCID-Profile: Toni Pihlaja

Förderung

  • Finland’s state funding for the university level

Zitieren

APA

Pihlaja, T., Ohtonen, P., Romsi, P., & Pokela, M. (2025). Sub-ulcer foam sclerotherapy in patients with venous ulceration: A randomized controlled trial. Phlebology: The Journal of Venous Disease. https://doi.org/10.1177/02683555241304030

Vancouver

Pihlaja T, Ohtonen P, Romsi P, Pokela M. Sub-ulcer foam sclerotherapy in patients with venous ulceration: A randomized controlled trial. Phlebology: The Journal of Venous Disease. 2025. doi:10.1177/02683555241304030

BibTeX
@article{Pihlaja2025,
  author = {Pihlaja, Toni and Ohtonen, Pasi and Romsi, Pekka and Pokela, Matti},
  title = {Sub-ulcer foam sclerotherapy in patients with venous ulceration: A randomized controlled trial},
  journal = {Phlebology: The Journal of Venous Disease},
  year = {2025},
  doi = {10.1177/02683555241304030}
}
Kostenlos starten →